New pill could tame skin lupus flares
Disease control
Not yet recruiting
This study tests an oral drug called ICP-488 for people with cutaneous lupus erythematosus (CLE), a condition that causes painful skin rashes and lesions. About 105 adults aged 18-75 will receive either the drug or a placebo for 16 weeks. The main goal is to see if the drug reduc…
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC